Shaker C Farah

9PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInfectious agentsPopular and genre literatureIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 08, 2024
Xanthomonas immunity proteins protect against the cis-toxic effects of their cognate T4SS effectors.

Gabriel U Oka, Diorge P Souza, Germán G Sgro

|Apr 26, 2022
Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCγ as an analgesic drug target.

Beatriz C Moraes, Helder V Ribeiro-Filho, Allan P Roldão

|Jan 05, 2022
Structural basis for effector recognition by an antibacterial type IV secretion system.

Gabriel U Oka, Diorge P Souza, William Cenens

|Aug 16, 2021
The PilB-PilZ-FimX regulatory complex of the Type IV pilus from Xanthomonas citri.

Edgar E Llontop, William Cenens, Denize C Favaro

|May 27, 2020
Bactericidal type IV secretion system homeostasis in Xanthomonas citri.

William Cenens, Maxuel O Andrade, Edgar Llontop

|Sep 13, 2019
The opportunistic pathogen Stenotrophomonas maltophilia utilizes a type IV secretion system for interbacterial killing.

Ethel Bayer-Santos, William Cenens, Bruno Yasui Matsuyama

Pageof 2